Cargando…

N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization

Many immune responses depend upon activation of NF-κB, an important transcription factor in the elicitation of a cytokine response. Here we show that N4BP1 inhibits TLR-dependent activation of NF-κB by interacting with the NF-κB signaling essential modulator (NEMO, also known as IκB kinase γ) to att...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hexin, Sun, Lei, Wang, Ying, Liu, Aijie, Zhan, Xiaoming, Li, Xiaohong, Tang, Miao, Anderton, Priscilla, Hildebrand, Sara, Quan, Jiexia, Ludwig, Sara, Moresco, Eva Marie Y., Beutler, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925594/
https://www.ncbi.nlm.nih.gov/pubmed/33654074
http://dx.doi.org/10.1038/s41467-021-21711-5
_version_ 1783659302781714432
author Shi, Hexin
Sun, Lei
Wang, Ying
Liu, Aijie
Zhan, Xiaoming
Li, Xiaohong
Tang, Miao
Anderton, Priscilla
Hildebrand, Sara
Quan, Jiexia
Ludwig, Sara
Moresco, Eva Marie Y.
Beutler, Bruce
author_facet Shi, Hexin
Sun, Lei
Wang, Ying
Liu, Aijie
Zhan, Xiaoming
Li, Xiaohong
Tang, Miao
Anderton, Priscilla
Hildebrand, Sara
Quan, Jiexia
Ludwig, Sara
Moresco, Eva Marie Y.
Beutler, Bruce
author_sort Shi, Hexin
collection PubMed
description Many immune responses depend upon activation of NF-κB, an important transcription factor in the elicitation of a cytokine response. Here we show that N4BP1 inhibits TLR-dependent activation of NF-κB by interacting with the NF-κB signaling essential modulator (NEMO, also known as IκB kinase γ) to attenuate NEMO–NEMO dimerization or oligomerization. The UBA-like (ubiquitin associated-like) and CUE-like (ubiquitin conjugation to ER degradation-like) domains in N4BP1 mediate interaction with the NEMO COZI domain. Both in vitro and in mice, N4bp1 deficiency specifically enhances TRIF-independent (TLR2, TLR7, or TLR9-mediated) but not TRIF-dependent (TLR3 or TLR4-mediated) NF-κB activation, leading to increased production of proinflammatory cytokines. In response to TLR4 or TLR3 activation, TRIF causes activation of caspase-8, which cleaves N4BP1 distal to residues D424 and D490 and abolishes its inhibitory effect. N4bp1(−/−) mice also have diminished numbers of T cells in the peripheral blood. Our work identifies N4BP1 as an inhibitory checkpoint protein that must be overcome to activate NF-κB, and a TRIF-initiated caspase-8-dependent mechanism by which this is accomplished.
format Online
Article
Text
id pubmed-7925594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79255942021-03-21 N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization Shi, Hexin Sun, Lei Wang, Ying Liu, Aijie Zhan, Xiaoming Li, Xiaohong Tang, Miao Anderton, Priscilla Hildebrand, Sara Quan, Jiexia Ludwig, Sara Moresco, Eva Marie Y. Beutler, Bruce Nat Commun Article Many immune responses depend upon activation of NF-κB, an important transcription factor in the elicitation of a cytokine response. Here we show that N4BP1 inhibits TLR-dependent activation of NF-κB by interacting with the NF-κB signaling essential modulator (NEMO, also known as IκB kinase γ) to attenuate NEMO–NEMO dimerization or oligomerization. The UBA-like (ubiquitin associated-like) and CUE-like (ubiquitin conjugation to ER degradation-like) domains in N4BP1 mediate interaction with the NEMO COZI domain. Both in vitro and in mice, N4bp1 deficiency specifically enhances TRIF-independent (TLR2, TLR7, or TLR9-mediated) but not TRIF-dependent (TLR3 or TLR4-mediated) NF-κB activation, leading to increased production of proinflammatory cytokines. In response to TLR4 or TLR3 activation, TRIF causes activation of caspase-8, which cleaves N4BP1 distal to residues D424 and D490 and abolishes its inhibitory effect. N4bp1(−/−) mice also have diminished numbers of T cells in the peripheral blood. Our work identifies N4BP1 as an inhibitory checkpoint protein that must be overcome to activate NF-κB, and a TRIF-initiated caspase-8-dependent mechanism by which this is accomplished. Nature Publishing Group UK 2021-03-02 /pmc/articles/PMC7925594/ /pubmed/33654074 http://dx.doi.org/10.1038/s41467-021-21711-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Shi, Hexin
Sun, Lei
Wang, Ying
Liu, Aijie
Zhan, Xiaoming
Li, Xiaohong
Tang, Miao
Anderton, Priscilla
Hildebrand, Sara
Quan, Jiexia
Ludwig, Sara
Moresco, Eva Marie Y.
Beutler, Bruce
N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization
title N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization
title_full N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization
title_fullStr N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization
title_full_unstemmed N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization
title_short N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization
title_sort n4bp1 negatively regulates nf-κb by binding and inhibiting nemo oligomerization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925594/
https://www.ncbi.nlm.nih.gov/pubmed/33654074
http://dx.doi.org/10.1038/s41467-021-21711-5
work_keys_str_mv AT shihexin n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT sunlei n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT wangying n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT liuaijie n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT zhanxiaoming n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT lixiaohong n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT tangmiao n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT andertonpriscilla n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT hildebrandsara n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT quanjiexia n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT ludwigsara n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT morescoevamariey n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization
AT beutlerbruce n4bp1negativelyregulatesnfkbbybindingandinhibitingnemooligomerization